Skip to Content

WATSON 415 (Estropipate 1.5 mg)

Pill with imprint WATSON 415 is Orange, Round and has been identified as Estropipate 1.5 mg. It is supplied by Watson Pharmaceuticals.

Estropipate is used in the treatment of atrophic vaginitis; hypoestrogenism; oophorectomy; osteoporosis; postmenopausal symptoms and belongs to the drug class estrogens. Not for use in pregnancy. Estropipate 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 415

Estropipate 1.5 mg WATSON 415
Estropipate 1.5 mg WATSON 415
Estropipate 1.5 mg WATSON 415  Front
Estropipate 1.5 mg WATSON 415  Back

Estropipate

Imprint
WATSON 415
Strength
1.5 mg
Color
Orange
Shape
Round
Availability
Prescription only
Drug Class
Estrogens
Pregnancy Category
X - Not for use in pregnancy
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
National Drug Code (NDC)
52544-0415

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.